# Tag: obesity drugs

- [The drug that is drying up consumption](https://brazilstockguide.com/behind-the-lines/the-drug-that-is-drying-up-consumption/) (2026-04-15): Rising use of weight-loss pens is cutting alcohol, snacks and dining out — and creating a new spending pattern.
- [Novo Nordisk Offers Free Wegovy Starter Dose as Semaglutide Patent Expires in Brazill](https://brazilstockguide.com/insights/novo-nordisk-offers-free-wegovy-starter-dose-as-semaglutide-patent-expires-in-brazill/) (2026-03-02): With semaglutide exclusivity ending March 20 and at least 20 generic applications filed, the Danish drugmaker moves to lock in patients.
- [XP Lifts Raia Drogasil to Buy as GLP-1 Drives New Growth Cycle](https://brazilstockguide.com/insights/xp-lifts-raia-drogasil-to-buy-as-glp-1-drives-new-growth-cycle/) (2025-12-07): Obesity and diabetes drugs, coming generics and HPC overhaul push price target to $6.30 by 2026.